Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...

書誌詳細
第一著者:	Hobbs, F
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
著者:: article Editorial
出版事項: (2020-09-01)

Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
著者:: Hobbs, R, 等
出版事項: (2005)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
著者:: Alberto J Lorenzatti, 等
出版事項: (2020-02-01)

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
著者:: Mach, F, 等
出版事項: (2019)

Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
著者:: Meor Anuar Shuhaili, Meor Fairuz Rizal, 等
出版事項: (2018)

Seasonal variation lipid levels in the patients with dyslipidaemia
著者:: I V Radysh, 等
出版事項: (2009-12-01)

Cardiovascular risk management in primary care.
著者:: Hobbs, F
出版事項: (2002)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
著者:: Francois Mach, 等
出版事項: (2020-06-01)

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
著者:: Sung-Bum Lee, 等
出版事項: (2022-07-01)

Current insights on dyslipidaemia management for prevention of atherosclerotic cardiovascular disease: a malaysian perspective
著者:: Wan Ahmad, Wan Azman, 等
出版事項: (2023)

Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
著者:: M R Essop, 等
出版事項: (2023-11-01)

Managing dyslipidaemia in patients with chronic kidney disease
著者:: Ashwani Mehta
出版事項: (2024-03-01)

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
著者:: Alicja E. Grzegorzewska, 等
出版事項: (2021-03-01)

Serum zinc levels in diabetic patients with and without dyslipidaemia and cardiovascular diseases
著者:: Lakmal Jayaweera, 等
出版事項: (2020-08-01)

Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension
著者:: Saxena S, 等
出版事項: (2015-07-01)

New concepts in the management of dyslipidaemia
著者:: Baris Gencer, 等
出版事項: (2016-11-01)

Managing dyslipidaemia in young adults
著者:: Jamshed J. Dalal, 等
出版事項: (2024-03-01)

Role of statins in the management of dyslipidaemia
著者:: Saumitra Ray
出版事項: (2024-03-01)

The changing paradigm of dyslipidaemia management
著者:: Ruvan Ekanayaka
出版事項: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
著者:: Iciar Martín-Timón, 等
出版事項: (2018-11-01)

The scale of heart failure: diagnosis and management issues for primary care.
著者:: Hobbs, F
出版事項: (1999)

Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.
著者:: Hobbs, F
出版事項: (2004)

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
著者:: Maciej Banach, 等
出版事項: (2022-09-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
著者:: Alberto Zambon
出版事項: (2020-04-01)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
著者:: Di Liu, 等
出版事項: (2018-08-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
著者:: Anandita Agarwala, 等
出版事項: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
著者:: Giuseppe Danilo Norata
出版事項: (2012-01-01)

Secondary dyslipidaemia
著者:: D.J. Blom
出版事項: (2011-07-01)

Diabetic dyslipidaemia
著者:: Subashini C. Thambiah, 等
出版事項: (2021-08-01)

Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
著者:: Martina Meszaros, 等
出版事項: (2022-10-01)

Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.
著者:: Erhardt, L, 等
出版事項: (2008)

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study
著者:: In Wong, 等
出版事項: (2020-01-01)

Optimisation of lipids for prevention of cardiovascular disease in a primary care
著者:: Smita Bakhai, 等
出版事項: (2018-07-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
著者:: Tiny Nair
出版事項: (2024-03-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
著者:: Alberico L. Catapano, 等
出版事項: (2017-06-01)

Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
著者:: Dalia Luksiene, 等
出版事項: (2014-01-01)

Dyslipidaemia and inflammatory markers as the risk predictors for cardiovascular disease in newly diagnosed premenopausal hypothyroid women
著者:: Balamurugan Vaideki, 等
出版事項: (2023-01-01)

Dyslipidaemia in endocrine disorders
著者:: Kalyani Sridharan, 等
出版事項: (2024-03-01)

Treatment of Dyslipidaemia in Children
著者:: Riccardo Fiorentino, 等
出版事項: (2021-08-01)

Dyslipidaemia in Sri Lanka
著者:: Anne Thushara Matthias, 等
出版事項: (2022-01-01)